Home > Healthcare > Medical Devices > Operating Room Supplies > Fluorescence Guided Surgery Systems Market

Fluorescence Guided Surgery Systems Market Size

Report ID: GMI9171
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Fluorescence Guided Surgery Systems Market Size

The fluorescence guided surgery systems market size was valued at around USD 101.3 million in 2023 and is estimated to grow at 14.1% CAGR from 2024 to 2032. Fluorescence-guided surgery (FGS) systems are advanced imaging systems used during surgical procedures to visualize and distinguish tissues with the help of fluorescent dyes.

To get key market trends

Download Free Sample

In FGS, a surgeon injects a fluorescent dye that selectively binds to specific tissues, such as tumors. Special cameras and imaging systems then detect the fluorescence, creating a visual contrast that allows the surgeon to identify and remove targeted tissues with higher precision. Chronic conditions such as cancer and cardiovascular diseases are rising globally, leading to a higher demand for advanced diagnostic and surgical technologies.

For instance, according to the International Agency for Research on Cancer (IARC) 2022 report, among 20 million new cancer cases worldwide, lung cancer and female breast cancer are the most common, representing 12.4% and 11.6% of cases, respectively. They are followed by colorectal cancer (9.6%), prostate cancer (7.3%), and stomach cancer (4.9%).

Fluorescence Guided Surgery Systems Market Report Attributes
Report Attribute	Details
Base Year:	2023
Fluorescence Guided Surgery Systems Market Size in 2023:	USD 101.3 Million
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	14.1%
2024 – 2032 Value Projection:	USD 330.7 Million
Historical Data for:	2021 – 2023
No. of Pages:	145
Tables, Charts & Figures:	189
Segments covered:	Type, Surgery, Application, End Use, & Region
Growth Drivers:	Increasing prevalence of chronic diseases Growth in targeted surgeries for cancer and cardiovascular disorders Growing focus towards improving surgical outcomes and reducing operating time Government initiatives aimed at improving surgical infrastructure
Pitfalls & Challenges:	High cost of surgical equipment and consumables Limited reimbursement coverage for fluorescence imaging procedures

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The fluorescence guided surgery systems industry was valued at around USD 101.3 million in 2023 and is estimated to grow at a 14.1% CAGR from 2024 to 2032, driven by advancements in imaging technology.

The SPY system segment dominated the market in 2023, accounting for a 38.1% share and a CAGR of 15%, due to its advanced imaging capabilities that enhance surgical precision.

U.S. dominated the North American fluorescence guided surgery systems industry with a revenue of USD 38.4 million in 2023, led by strong R&D efforts and medical technology innovation.

Key players in the market include B. Braun, Carl Zeiss, Danaher Corporation, Getinge, Hamamatsu Photonics, Intuitive Surgical, KARL STORZ, Medtronic, and Olympus Corporation.